Preferred Label : amprenavir;

MeSH note : structure in first source; RN refers to (3S-(3R*(1S*,2R*)))-isomer; fosamprenavir is a prodrug;

CISMeF synonym : 141W94; VX 478; agenerase; GlaxoSmithKline brand of amprenavir; glaxo wellcome brand of amprenavir;

MeSH synonym : tetrahydro-3-furyl N-(3-(4-amino-N-isobutylbenzenesulfonamido)-1-benzyl-2-hydroxypropyl)carbamate; (3S-(3R*(1R*,2S*)))-(3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl) tetrahydro-3-furanyl carbamate;

MeSH hyponym : VX-478; Vertex VX478;

MeSH Related Number : 161814-49-9;

Registry Number MeSH : 161814-49-9;

Is substance : O;

UNII : 5S0W860XNR;

InChIKey : YMARZQAQMVYCKC-OEMFJLHTSA-N;

Details


Main resources

You can consult :


https://www.ema.europa.eu/medicines/human/EPAR/Agenerase
2011
false
United Kingdom
English
French
syndication feed
Contraindications, Procedure
sulfonamides
sulfonamides
sulfonamides
anti-hiv agents
anti-hiv agents
anti-hiv agents
anti-hiv agents
anti-hiv agents
anti-hiv agents
hiv protease inhibitors
hiv protease inhibitors
hiv protease inhibitors
hiv protease inhibitors
hiv protease inhibitors
hiv protease inhibitors
amprenavir
child
anti-hiv agents
hiv infections
HIV-1
hiv protease inhibitors
treatment outcome
drug evaluation
pregnancy
breast feeding
drug labeling
drug approval
drug evaluation, preclinical
administration, oral
sulfonamides
capsules
carbamates
adult
carbamates
carbamates
carbamates
carbamates
drug interactions
carbamates
drug resistance, viral
carbamates
sulfonamides
sulfonamides
sulfonamides
amprenavir
carbamates
sulfonamides
drug evaluation
summary of product characteristics
package leaflet
Contraindications, Drug

---
http://www.has-sante.fr/portail/display.jsp?id=c_631245
2008
France
French
carbamates
sulfonamides
anti-hiv agents
hiv protease inhibitors
capsules
pharmaceutical solutions
administration, oral
adult
child
adolescent
insurance, health, reimbursement
hiv infections
HIV-1
drug therapy, combination
amprenavir
amprenavir
carbamates
sulfonamides
evaluation of the transparency committee

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61146564
2008
France
French
carbamates
pharmaceutical solutions
administration, oral
sulfonamides
amprenavir
amprenavir
drug information

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61403507
2008
France
French
capsules
administration, oral
carbamates
sulfonamides
amprenavir
amprenavir
drug information

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63831912
2008
France
French
capsules
administration, oral
sulfonamides
carbamates
amprenavir
amprenavir
drug information

---
http://www.has-sante.fr/portail/display.jsp?id=c_398814
2001
France
French
sulfonamides
anti-hiv agents
hiv protease inhibitors
administration, oral
carbamates
capsules
pharmaceutical solutions
insurance, health, reimbursement
drug interactions
hiv infections
HIV-1
adult
child
adolescent
drug therapy, combination
treatment outcome
hiv protease inhibitors
anti-hiv agents
sulfonamides
carbamates
amprenavir
amprenavir
amprenavir
carbamates
sulfonamides
evaluation of the transparency committee

---
Nous contacter.
02/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.